New UK trial looks to reduce COVID-19 drug development to a few weeks

The new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks. The ACCORD-2 collaboration will examine the effectiveness of repurposed medicines, potential new drugs, and currently unlicensed therapies in treating COVID-19 patients. Drug compounds that demonstrate effectiveness and safety in the early clinical trials stage

Continue Reading

A Future of Work Institute Webinar Series “Leading Through Times of Change”

During times of change it can be challenging for organisations to focus on business strategy while maintaining employee engagement, productivity and wellness. Now more than ever, your leadership style, employer proposition and employee experience are important. As we all adapt to new ways of working implementing and adopting virtual interviews and onboarding are a challenge.

Continue Reading

Working from Home Hacks

After the success of the recent article on the Clinical Professionals blog about working from home tips and tricks, below are some tips that can help make life just a little bit easier. Get up an hour before you need to work Last thing you want to do whilst working from home is to roll

Continue Reading

“Safety does not come with luck. It must be prepared” – Pharmacovigilance Report

Our latest industry analytics report features analysis on the drug safety sector within the life sciences industry. Clinical Professionals Group CEO, Yvette Cleland comments: “The global pharmacovigilance (PV) market size was estimated at $4.87 billion in 2019, according to a Global Market Insights report, by 2024 the market is predicted to exceed US$8 billion .

Continue Reading